Kretzschmar, HA, Ironside, JW, DeArmond, SJ, Tateishi, J. Diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Arch Neurol. 1996;53(9):913–20.CrossRefGoogle ScholarPubMed

Wall, CA, Rummans, TA, Aksamit, AJ, Krahn, LE, Pankratz, VS. Psychiatric manifestations of Creutzfeldt-Jakob disease: a 25-year analysis. The Journal of Neuropsychiatry and Clinical Neurosciences. 2005;17(4):489–95.CrossRefGoogle ScholarPubMed

Geschwind, MD, Shu, H, Haman, A, Sejvar, JJ, Miller, BL. Rapidly progressive dementia. Ann Neurol. 2008;64(1):97–108.CrossRefGoogle ScholarPubMed

Prusiner, SB. Prions. Proc Natl Acad Sci USA. 1998;95(23):13363–83.CrossRefGoogle Scholar

Will, RG, Alperovitch, A, Poser, S, Pocchiari, M, Hofman, A, Mitrova, E, et al. Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993–1995. EU Collaborative Study Group for CJD. Ann Neurol. 1998;43(6):763–7.CrossRefGoogle ScholarPubMed

Holman, RC, Belay, ED, Christensen, KY, Maddox, RA, Minino, AM, Folkema, AM, et al. Human prion diseases in the United States. PLoS One. 2010;5(1):e8521.CrossRefGoogle ScholarPubMed

Ladogana, A, Puopolo, M, Croes, EA, Budka, H, Jarius, C, Collins, S, et al. Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada. Neurology. 2005;64(9):1586–91.Google Scholar

UK National CJD Surveillance Unit. Variant Creutzfeldt-Jakob disease Worldwide Current Data (June 2014) [electronic]. Edinburgh: Western General Hospital; 2014 [updated June 2014; cited 2014 6/27/2014]. Available from: http://www.cjd.ed.ac.uk/documents/worldfigs.pdf.CrossRefGoogle ScholarPubMed

Heath, CA, Cooper, SA, Murray, K, Lowman, A, Henry, C, MacLeod, MA, et al. Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease. Ann Neurol. 2010;67(6):761–70.CrossRefGoogle ScholarPubMed

Brown, P, Brandel, JP, Preece, M, Sato, T. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology. 2006;67(3):389–93.CrossRefGoogle ScholarPubMed

Cockcroft, PD, Clark, AM. The Shetland Islands scrapie monitoring and control programme: analysis of the clinical data collected from 772 scrapie suspects 1985–1997. Research in Veterinary Science. 2006;80(1):33–44.Google Scholar

Liberski, PP. Kuru and D. Carleton Gajdusek: a close encounter. Folia Neuropathol. 2009;47(2):114–37.CrossRefGoogle ScholarPubMed

Gajdusek, DC. Unconventional viruses and the origin and disappearance of kuru. Science. 1977;197(4307):943–60.CrossRefGoogle ScholarPubMed

Poser, CM. Notes on the history of the prion diseases. Part II. Clin Neurol Neurosurg. 2002;104(2):77–86.Google Scholar

Hadlow, WJ. Scrapie and kuru. Lancet 1959;2:289–90.CrossRefGoogle ScholarPubMed

Pattison, IH. Resistance of the scrapie agent to formalin. J Comp Pathol. 1965;75:159–64.CrossRefGoogle ScholarPubMed

Mould, DL, Dawson, AM, Smith, W. Scrapie in mice. The stability of the agent to various suspending media, pH and solvent extraction. Research in Veterinary Science. 1965;6:151–4.CrossRefGoogle ScholarPubMed

Hunter, GD, Millson, GC. Studies on the heat stability and chromatographic behaviour of the scrapie agent. Journal of General Microbiology. 1964;37:251–8.CrossRefGoogle ScholarPubMed

Alper, T, Haig, DA, Clarke, MC. The exceptionally small size of the scrapie agent. Biochemical and Biophysical Research Communications. 1966;22(3):278–84.CrossRefGoogle ScholarPubMed

Gibbs, CJ Jr., Gajdusek, DC, Latarjet, R. Unusual resistance to ionizing radiation of the viruses of kuru, Creutzfeldt-Jakob disease, and scrapie. Proc Natl Acad Sci USA. 1978;75(12):6268–70.CrossRefGoogle Scholar

Diener, TO, McKinley, MP, Prusiner, SB. Viroids and prions. Proc Natl Acad Sci USA. 1982;79(17):5220–4.CrossRefGoogle ScholarPubMed

Prusiner, SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216(4542):136–44.CrossRefGoogle ScholarPubMed

Carp, RI, Merz, PA, Kascsak, RJ, Merz, GS, Wisniewski, HM. Nature of the scrapie agent: current status of facts and hypotheses. The Journal of General Virology. 1985;66 ( Pt 7):1357–68.CrossRefGoogle ScholarPubMed

Basler, K, Oesch, B, Scott, M, Westaway, D, Walchli, M, Groth, DF, et al. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell. 1986;46(3):417–28.CrossRefGoogle Scholar

Robakis, NK, Devine-Gage, EA, Jenkins, EC, Kascsak, RJ, Brown, WT, Krawczun, MS, et al. Localization of a human gene homologous to the PrP gene on the p arm of chromosome 20 and detection of PrP-related antigens in normal human brain. Biochemical and Biophysical Research Communications. 1986;140(2):758–65.CrossRefGoogle ScholarPubMed

Wopfner, F, Weidenhofer, G, Schneider, R, von Brunn, A, Gilch, S, Schwarz, TF, et al. Analysis of 27 mammalian and 9 avian PrPs reveals high conservation of flexible regions of the prion protein. J Mol Biol. 1999;289(5):1163–78.CrossRefGoogle ScholarPubMed

Stahl, N, Baldwin, MA, Teplow, DB, Hood, L, Gibson, BW, Burlingame, AL, et al. Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry. 1993;32(8):1991–2002.CrossRefGoogle ScholarPubMed

Hsiao, K, Baker, HF, Crow, TJ, Poulter, M, Owen, F, Terwilliger, JD, et al. Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature. 1989;338(6213):342–5.CrossRefGoogle ScholarPubMed

Colby, DW, Prusiner, SB. Prions. Cold Spring Harbor Perspectives in Biology. 2011;3(1):a006833.Google Scholar

Lloyd, S, Mead, S, Collinge, J. Genetics of prion disease. In Tatzelt, J, editor. Prion Proteins. Topics in Current Chemistry. 305. Berlin Heidelberg: Springer; 2011. pp. 1–22.CrossRefGoogle ScholarPubMed

Budka, H. Neuropathology of prion diseases. Br Med Bull. 2003;66:121–30.Google ScholarPubMed

Liberski, PP, Ironside, JW. An outline of the neuropathology of transmissible spongiform encephalopathies (prion diseases). Folia Neuropathol. 2004;42 (Suppl B):39–58.CrossRefGoogle ScholarPubMed

Brown, K, Mastrianni, JA. The prion diseases. J Geriatr Psychiatry Neurol. 2010;23(4):277–98.CrossRefGoogle ScholarPubMed

Creutzfeldt, HG. On a particular focal disease of the central nervous system (preliminary communication), 1920. Alzheimer Dis Assoc Disord. 1989;3(1–2):3–25.CrossRefGoogle ScholarPubMed

Jakob, A. Concerning a disorder of the central nervous system clinically resembling multiple sclerosis with remarkable anatomic findings (spastic pseudosclerosis). Report of a fourth case. Alzheimer Dis Assoc Disord. 1989;3(1–2):26–45.CrossRefGoogle ScholarPubMed

Katscher, F. It's Jakob's disease, not Creutzfeldt's. Nature. 1998;393(6680):11.Google Scholar

Masters, CL, Gadjusek, DC. The spectrum of Creutzfeldt-Jakob disease and the virus-induced subacute spongiform encephalopathies. In Smith, WT, Cavanagh, JB, editors. Recent Advances in Neuropathology Number 2. Edinburgh: Churchill Livingstone; 1982. pp. 139–63.Google Scholar

Richardson, EP Jr. Introduction to myoclonic dementia. In Rottenber, DA, Hochberg, FH, editors. Neurological Classics in Modern Translation. New York: Haffner Press; 1977. pp. 95–6.CrossRefGoogle ScholarPubMed

Masters, CL. Creutzfeldt-Jakob disease: its origins. Alzheimer Dis Assoc Disord. 1989;3(1–2):46–51.CrossRefGoogle Scholar

Heidenhain, A. Klinische und anatomische Untersuchungen über eine eigenartige organische Erkrankung des Zentralnervensystems im Praesenium. Z Gesamte Neurol Psychiat. 1929;118:49–114.CrossRefGoogle ScholarPubMed

Puoti, G, Bizzi, A, Forloni, G, Safar, JG, Tagliavini, F, Gambetti, P. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol. 2012;11(7):618–28.3.0.CO;2-W>CrossRefGoogle ScholarPubMed

Parchi, P, Giese, A, Capellari, S, Brown, P, Schulz-Schaeffer, W, Windl, O, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol. 1999;46(2):224–33.CrossRefGoogle ScholarPubMed

Parchi, P, Capellari, S, Chin, S, Schwarz, HB, Schecter, NP, Butts, JD, et al. A subtype of sporadic prion disease mimicking fatal familial insomnia. Neurology. 1999;52(9):1757–63.Google ScholarPubMed

Parchi, P, Saverioni, D. Molecular pathology, classification, and diagnosis of sporadic human prion disease variants. Folia Neuropathol. 2012;50(1):20–45.CrossRefGoogle ScholarPubMed

Head, MW, Ironside, JW. Sporadic Creutzfeldt-Jakob disease: discrete subtypes or a spectrum of disease? Brain. 2009;132(Pt 10):2627–9.CrossRefGoogle ScholarPubMed

Meissner, B, Kallenberg, K, Sanchez-Juan, P, Collie, D, Summers, DM, Almonti, S, et al. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology. 2009;72(23):1994–2001.CrossRefGoogle ScholarPubMed

Hamaguchi, T, Kitamoto, T, Sato, T, Mizusawa, H, Nakamura, Y, Noguchi, M, et al. Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease. Neurology. 2005;64(4):643–8.CrossRefGoogle ScholarPubMed

Brown, P, Cathala, F, Castaigne, P, Gajdusek, DC. Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Ann Neurol. 1986;20(5):597–602.CrossRefGoogle ScholarPubMed

Johnson, DY, Dunkelberger, DL, Henry, M, Haman, A, Greicius, MD, Wong, K, et al. Sporadic Jakob-Creutzfeldt disease presenting as primary progressive aphasia. JAMA Neurol. 2013;70(2):254–7.CrossRefGoogle ScholarPubMed

Pocchiari, M, Puopolo, M, Croes, EA, Budka, H, Gelpi, E, Collins, S, et al. Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain. 2004;127(10):2348–59.Google ScholarPubMed

Brown, P, Cathala, F, Sadowsky, D, Gajdusek, DC. Creutzfeldt-Jakob disease in France: II. Clinical characteristics of 124 consecutive verified cases during the decade 1968–1977. Ann Neurol. 1979;6(5):430–7.CrossRefGoogle ScholarPubMed

Rabinovici, GD, Wang, PN, Levin, J, Cook, L, Pravdin, M, Davis, J, et al. First symptom in sporadic Creutzfeldt-Jakob disease. Neurology. 2006;66(2):286–7.CrossRefGoogle ScholarPubMed

Will, RG, Matthews, WB. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970–79. I: Clinical features. J Neurol Neurosurg Psychiatry. 1984;47(2):134–40.CrossRefGoogle ScholarPubMed

Martory, MD, Roth, S, Lovblad, KO, Neumann, M, Lobrinus, JA, Assal, F. Creutzfeldt-Jakob disease revealed by a logopenic variant of primary progressive aphasia. Eur Neurol. 2012;67(6):360–2.CrossRefGoogle ScholarPubMed

Kobylecki, C, Thompson, JC, Jones, M, Mills, SJ, Shaunak, S, Ironside, JW, et al. Sporadic Creutzfeldt-Jakob disease presenting as progressive nonfluent aphasia with speech apraxia. Alzheimer Dis Assoc Disord. 2013;27(4):384–6.CrossRefGoogle ScholarPubMed

Depaz, R, Haik, S, Peoc'h, K, Seilhean, D, Grabli, D, Vicart, S, et al. Long-standing prion dementia manifesting as posterior cortical atrophy. Alzheimer Dis Assoc Disord. 2012;26(3):289–92.CrossRefGoogle ScholarPubMed

Lee, W, Simpson, M, Ling, H, McLean, C, Collins, S, Williams, DR. Characterising the uncommon corticobasal syndrome presentation of sporadic Creutzfeldt-Jakob disease. Parkinsonism Relat Disord. 2013;19(1):81–5.CrossRefGoogle ScholarPubMed

Shimamura, M, Uyama, E, Hirano, T, Murakami, T, Mita, S, Kitamoto, T, et al. A unique case of sporadic Creutzfeldt-Jacob disease presenting as progressive supranuclear palsy. Intern Med. 2003;42(2):195–8.CrossRefGoogle ScholarPubMed

Matej, R, Kovacs, GG, Johanidesova, S, Keller, J, Matejckova, M, Novakova, J, et al. Genetic Creutzfeldt-Jakob disease with R208H mutation presenting as progressive supranuclear palsy. Mov Disord. 2012;27(4):476–9.CrossRefGoogle ScholarPubMed

Josephs, KA, Tsuboi, Y, Dickson, DW. Creutzfeldt-Jakob disease presenting as progressive supranuclear palsy. Eur J Neurol. 2004;11(5):343–6.CrossRefGoogle ScholarPubMed

Plate, A, Benninghoff, J, Jansen, GH, Wlasich, E, Eigenbrod, S, Drzezga, A, et al. Atypical parkinsonism due to a D202N Gerstmann-Straussler-Scheinker prion protein mutation: first in vivo diagnosed case. Mov Disord. 2013;28(2):241–4.CrossRefGoogle ScholarPubMed

Nitrini, R, Teixeira da Silva, LS, Rosemberg, S, Caramelli, P, Carrilho, PE, Iughetti, P, et al. Prion disease resembling frontotemporal dementia and parkinsonism linked to chromosome 17. Arquivos de Neuro-Psiquiatria. 2001;59(2-A):161–4.CrossRefGoogle ScholarPubMed

Mittal, M, Hammond, N, Husmann, K, Lele, A, Pasnoor, M. Creutzfeldt-Jakob disease presenting as bulbar palsy. Muscle Nerve. 2010;42(5):833–5.CrossRefGoogle ScholarPubMed

Marek, M, Klockgether, T, Urbach, H, Zerr, I, Kretzschmar, H, Paus, S. Isolated spasticity in sporadic Creutzfeldt-Jakob disease. J Neurol. 2013;260(2):654–5.CrossRefGoogle ScholarPubMed

Geevasinga, N, Simon, NG, Collins, S, Buckland, ME, Ng, K. Sporadic Creutzfeldt-Jakob disease presenting as spastic paraparesis. Eur J Neurol. 2013;20(5):e73–4.CrossRefGoogle ScholarPubMed

Thompson, A, MacKay, A, Rudge, P, Lukic, A, Porter, MC, Lowe, J, et al. Behavioral and psychiatric symptoms in prion disease. The American Journal of Psychiatry. 2014;171(3):265–74.Google ScholarPubMed

Appleby, BS, Appleby, KK, Crain, BJ, Onyike, CU, Wallin, MT, Rabins, PV. Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants. Arch Neurol. 2009;66(2):208–15.CrossRefGoogle ScholarPubMed

Paterson, RW, Torres-Chae, CC, Kuo, AL, Ando, T, Nguyen, EA, Wong, K, et al. Differential diagnosis of Jakob-Creutzfeldt disease. Arch Neurol. 2012;69(12):1578–82.CrossRefGoogle ScholarPubMed

Chitravas, N, Jung, RS, Kofskey, DM, Blevins, JE, Gambetti, P, Leigh, RJ, et al. Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease. Ann Neurol. 2011;70(3):437–44.CrossRefGoogle ScholarPubMed

Vitali, P, Maccagnano, E, Caverzasi, E, Henry, RG, Haman, A, Torres-Chae, C, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 2011;76(20):1711–19.Google Scholar

Shiga, Y, Miyazawa, K, Sato, S, Fukushima, RS, Shibuya, S, Sato, Y, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease. Neurology. 2004;I63:443–9.Google Scholar

Geschwind, MD, Kuryan, C, Cattaruzza, T, Vitali, P, DeArmond, S, Wong, K. Brain MRI in sporadic Jakob-Creutzfeldt disease is often misread. Neurology. 2010;74(Suppl 2):A213.CrossRefGoogle ScholarPubMed

Carswell, C, Thompson, A, Lukic, A, Stevens, J, Rudge, P, Mead, S, et al. MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease. BMC Neurol. 2012;12(1):153.Google ScholarPubMed

Young, GS, Geschwind, MD, Fischbein, NJ, Martindale, JL, Henry, RG, Liu, S, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol. 2005;26(6):1551–62.CrossRefGoogle ScholarPubMed

Zerr, I, Kallenberg, K, Summers, DM, Romero, C, Taratuto, A, Heinemann, U, et al. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain. 2009;132(Pt 10):2659–68.Google Scholar

Vitali, P, Haman, A, Torres-Chae, C, Maccagnano, E, R.G. H, Miller, BL, et al. Improving MRI Criteria for Jakob-Creutzfeldt Disease (CJD) by the pattern of gray matter involvement on FLAIR and DWI MRI (IN2-2.005). Neurology. 2008;70(Suppl 1):A8.CrossRefGoogle ScholarPubMed

Letourneau-Guillon, L, Wada, R, Kucharczyk, W. Imaging of prion diseases. J Magn Reson Imaging. 2012;35(5):998–1012.CrossRefGoogle Scholar

Rosenbloom, M, Tartaglia, MC, Forner, SA, Wong, K, Kuo, A, Johnson, DY, et al. Metabolic disorders with clinical and radiological features of sporadic Jakob-Creutzfeldt Disease. Neurol Clin Pract. 2015 April;5(2):108–15.CrossRefGoogle ScholarPubMed

Steinhoff, BJ, Zerr, I, Glatting, M, Schulz-Schaeffer, W, Poser, S, Kretzschmar, HA. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol. 2004;56(5):702–8.CrossRefGoogle ScholarPubMed

Seipelt, M, Zerr, I, Nau, R, Mollenhauer, B, Kropp, S, Steinhoff, BJ, et al. Hashimoto's encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 1999;66(2):172–6.CrossRefGoogle ScholarPubMed

Tschampa, HJ, Neumann, M, Zerr, I, Henkel, K, Schroter, A, Schulz-Schaeffer, WJ, et al. Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 2001;71(1):33–9.CrossRefGoogle ScholarPubMed

Green, A, Sanchez-Juan, P, Ladogana, A, Cuadrado-Corrales, N, Sanchez-Valle, R, Mitrova, E, et al. CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies. Eur J Neurol. 2007;14(2):121–4.CrossRefGoogle ScholarPubMed

Paterson, RW, Takada, LT, Geschwind, MD. Diagnosis and treatment of rapidly progressive dementias. Neurol Clin Pract. 2012;2(3):187–200.CrossRefGoogle ScholarPubMed

Hsich, G, Kenney, K, Gibbs, CJ, Lee, KH, Harrington, MG. The 14–3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med. 1996;335(13):924–30.CrossRefGoogle ScholarPubMed

Chapman, T, McKeel, DW Jr., Morris, JC. Misleading results with the 14–3-3 assay for the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2000;55(9):1396–7.CrossRefGoogle ScholarPubMed

Sanchez-Juan, P, Green, A, Ladogana, A, Cuadrado-Corrales, N, Sanchez-Valle, R, Mitrovaa, E, et al. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease. Neurology. 2006;67(4):637–43.CrossRefGoogle Scholar

Chohan, G, Pennington, C, Mackenzie, JM, Andrews, M, Everington, D, Will, RG, et al. The role of cerebrospinal fluid 14–3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review. J Neurol Neurosurg Psychiatry. 2010;81(11):1243–8.CrossRefGoogle ScholarPubMed

Hamlin, C, Puoti, G, Berri, S, Sting, E, Harris, C, Cohen, M, et al. A comparison of tau and 14–3-3 protein in the diagnosis of Creutzfeldt-Jakob disease. Neurology. 2012;79(6):547–52.CrossRefGoogle Scholar

Coulthart, MB, Jansen, GH, Olsen, E, Godal, DL, Connolly, T, Choi, BC, et al. Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study. BMC Neurol. 2011;11:133.CrossRefGoogle ScholarPubMed

van Harten, AC, Kester, MI, Visser, PJ, Blankenstein, MA, Pijnenburg, YA, van der Flier, WM, et al. Tau and p-tau as CSF biomarkers in dementia: a meta-analysis. Clin Chem Lab Med. 2011;49(3):353–66.CrossRefGoogle ScholarPubMed

Skillback, T, Rosen, C, Asztely, F, Mattsson, N, Blennow, K, Zetterberg, H. Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry. JAMA Neurol. 2014;71(4):476–83.CrossRefGoogle ScholarPubMed

Satoh, J, Kurohara, K, Yukitake, M, Kuroda, Y. The 14–3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture. Eur Neurol. 1999;41(4):216–25.CrossRefGoogle ScholarPubMed

Shimada, T, Fournier, AE, Yamagata, K. Neuroprotective function of 14–3-3 proteins in neurodegeneration. BioMed Res Int. 2013;2013:564534.CrossRefGoogle ScholarPubMed

Geschwind, MD, Martindale, J, Miller, D, DeArmond, SJ, Uyehara-Lock, J, Gaskin, D, et al. Challenging the clinical utility of the 14–3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol. 2003;60(6):813–16.CrossRefGoogle ScholarPubMed

Pruss, H, Dalmau, J, Harms, L, Holtje, M, Ahnert-Hilger, G, Borowski, K, et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology. 2010;75(19):1735–9.CrossRefGoogle Scholar

Muayqil, T, Gronseth, G, Camicioli, R. Evidence-based guideline: diagnostic accuracy of CSF 14–3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology. Neurology. 2012;79(14):1499–506.CrossRefGoogle ScholarPubMed

Atarashi, R, Satoh, K, Sano, K, Fuse, T, Yamaguchi, N, Ishibashi, D, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med. 2011;17(2):175–8.CrossRefGoogle ScholarPubMed

Orru, CD, Bongianni, M, Tonoli, G, Ferrari, S, Hughson, AG, Groveman, BR, et al. A test for Creutzfeldt-Jakob disease using nasal brushings. N Engl J Med. 2014;371(6):519–29.CrossRefGoogle ScholarPubMed

McGuire, LI, Peden, AH, Orru, CD, Wilham, JM, Appleford, NE, Mallinson, G, et al. Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann Neurol. 2012;72(2):278–85.CrossRefGoogle ScholarPubMed

Gambetti, P, Dong, Z, Yuan, J, Xiao, X, Zheng, M, Alshekhlee, A, et al. A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol. 2008;63(6):697–708.CrossRefGoogle ScholarPubMed

Diack, AB, Ritchie, DL, Peden, AH, Brown, D, Boyle, A, Morabito, L, et al. Variably protease-sensitive prionopathy, a unique prion variant with inefficient transmission properties. Emerg Infect Dis. 2014;20(12):1969–79.CrossRefGoogle Scholar

Head, MW, Yull, HM, Ritchie, DL, Langeveld, JP, Fletcher, NA, Knight, RS, et al. Variably protease-sensitive prionopathy in the UK: a retrospective review 1991–2008. Brain. 2013;136(Pt 4):1102–15.Google Scholar

WHO. Global Surveillance, Diagnosis and Therapy of Human Transmissible Spongiform Encephalopathies: Report of a WHO Consultation Geneva, Switzerland 9–11 February 1998. Geneva, Switzerland: World Health Organization, 1998.CrossRefGoogle ScholarPubMed

Mastrianni, JA. The genetics of prion diseases. Genet Med. 2010; 12(4):187–95.CrossRefGoogle ScholarPubMed

Lloyd, SE, Mead, S, Collinge, J. Genetics of prion diseases. Current Op Gen Dev. 2013;23(3):345–51.CrossRefGoogle ScholarPubMed

Lloyd, S, Mead, S, Collinge, J. Genetics of prion disease. Topics in Current Chemistry. 2011;305:1–22.CrossRefGoogle ScholarPubMed

Kovacs, GG, Puopolo, M, Ladogana, A, Pocchiari, M, Budka, H, van Duijn, C, et al. Genetic prion disease: the EUROCJD experience. Human Genetics. 2005;118(2):166–74.CrossRefGoogle ScholarPubMed

Vitali, P, Migliaccio, R, Agosta, F, Rosen, HJ, Geschwind, MD. Neuroimaging in dementia. Seminars in Neurology. 2008;28(4):467–83.CrossRefGoogle ScholarPubMed

Yang, TI, Jung, DS, Ahn, BY, Jeong, BH, Cho, HJ, Kim, YS, et al. Familial Creutzfeldt-Jakob disease with V180I mutation. Journal of Korean Medical Science. 2010;25(7):1097–100.CrossRefGoogle Scholar

Laplanche, JL, Hachimi, KH, Durieux, I, Thuillet, P, Defebvre, L, Delasnerie-Laupretre, N, et al. Prominent psychiatric features and early onset in an inherited prion disease with a new insertional mutation in the prion protein gene. Brain. 1999;122 (Pt 12):2375–86.CrossRefGoogle Scholar

Webb, TE, Poulter, M, Beck, J, Uphill, J, Adamson, G, Campbell, T, et al. Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain. 2008;131(Pt 10):2632–46.CrossRefGoogle ScholarPubMed

Goldfarb, LG, Petersen, RB, Tabaton, M, Brown, P, LeBlanc, AC, Montagna, P, et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science. 1992;258(5083):806–8.CrossRefGoogle Scholar

McLean, CA, Storey, E, Gardner, RJ, Tannenberg, AE, Cervenakova, L, Brown, P. The D178N (cis-129M) "fatal familial insomnia" mutation associated with diverse clinicopathologic phenotypes in an Australian kindred. Neurology. 1997;49(2):552–8.CrossRefGoogle ScholarPubMed

Cortelli, P, Perani, D, Montagna, P, Gallassi, R, Tinuper, P, Provini, F, et al. Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies. Brain. 2006;129(Pt 3):668–75.CrossRefGoogle ScholarPubMed

Will, RG, Ironside, JW, Zeidler, M, Cousens, SN, Estibeiro, K, Alperovitch, A, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 1996;347(9006):921–5.CrossRefGoogle ScholarPubMed

Norrby, E. Prions and protein-folding diseases. J Int Med. 2011; 270(1):1–14.Google Scholar

ECDC. Variant CJD Factsheet: European Centre for Disease Prevention and Control; 2015 [updated April 2015; cited 2015 May 29]. Information on variant CJD. Available from: http://ecdc.europa.eu/en/healthtopics/Variant_Creutzfeldt-Jakob_disease%28vCJD%29/Pages/factsheet_health_professionals.aspx.CrossRefGoogle ScholarPubMed

Maheshwari, A, Fischer, M, Gambetti, P, Parker, AR, Soto, C, Luis Concha-Marambio, YC, et al. Recent US case of variant Creutzfeldt-Jakob disease – global implications. Emerg Infect Dis. 2015;21(5):750–9.Google ScholarPubMed

Ironside, JW. Variant Creutzfeldt-Jakob disease: an update. Folia Neuropathol. 2012;50(1):50–6.CrossRefGoogle ScholarPubMed

Knight, R. The risk of transmitting prion disease by blood or plasma products. Transfus Apher Sci. 2010;43(3):387–91.CrossRefGoogle ScholarPubMed

Salmon, R. How widespread is variant Creutzfeldt-Jakob disease? BMJ. 2013;347:f5994.CrossRefGoogle ScholarPubMed

de Marco, MF, Linehan, J, Gill, ON, Clewley, JP, Brandner, S. Large-scale immunohistochemical examination for lymphoreticular prion protein in tonsil specimens collected in Britain. The Journal of Pathology. 2010;222(4):380–7.CrossRefGoogle ScholarPubMed

Clewley, JP, Kelly, CM, Andrews, N, Vogliqi, K, Mallinson, G, Kaisar, M, et al. Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross-sectional opportunistic survey. BMJ. 2009;338:b1442.CrossRefGoogle ScholarPubMed

Heath, CA, Cooper, SA, Murray, K, Lowman, A, Henry, C, Macleod, MA, et al. Diagnosing variant Creutzfeldt-Jakob disease: a retrospective analysis of the first 150 cases in the UK. J Neurol Neurosurg Psychiatry. 2011;82(6):646–51.Google Scholar

UK National CJD Surveillance Unit. Variant Creutzfeldt-Jakob disease Worldwide Current Data (May 2016) [electronic]. Edinburgh: Western General Hospital; 2016 [updated May 2016; cited 2016 June 5]. Available from: http://www.cjd.ed.ac.uk/documents/worldfigs.pdf.CrossRefGoogle Scholar

Kaski, D, Mead, S, Hyare, H, Cooper, S, Jampana, R, Overell, J, et al. Variant CJD in an individual heterozygous for PRNP codon 129. Lancet. 2009;374(9707):2128.CrossRefGoogle ScholarPubMed

Petzold, GC, Westner, I, Bohner, G, Einhaupl, KM, Kretzschmar, HA, Valdueza, JM. False-positive pulvinar sign on MRI in sporadic Creutzfeldt-Jakob disease. Neurology. 2004;62(7):1235–6.CrossRefGoogle ScholarPubMed

Haik, S, Brandel, JP, Oppenheim, C, Sazdovitch, V, Dormont, D, Hauw, JJ, et al. Sporadic CJD clinically mimicking variant CJD with bilateral increased signal in the pulvinar. Neurology. 2002;58(1):148–9.3.0.CO;2-W>CrossRefGoogle ScholarPubMed

Will, RG, Zeidler, M, Stewart, GE, Macleod, MA, Ironside, JW, Cousens, SN, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol. 2000;47(5):575–82.CrossRefGoogle Scholar

Binelli, S, Agazzi, P, Giaccone, G, Will, RG, Bugiani, O, Franceschetti, S, et al. Periodic electroencephalogram complexes in a patient with variant Creutzfeldt-Jakob disease. Ann Neurol. 2006;59(2):423–7.CrossRefGoogle ScholarPubMed

Hill, AF, Butterworth, RJ, Joiner, S, Jackson, G, Rossor, MN, Thomas, DJ, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet. 1999;353(9148):183–9.CrossRefGoogle ScholarPubMed

Brown, P, Brandel, JP, Sato, T, Nakamura, Y, MacKenzie, J, Will, RG, et al. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis. 2012;18(6):901–7.CrossRefGoogle Scholar

Will, RG. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br Med Bull. 2003;66:255–65.CrossRefGoogle ScholarPubMed

Abrams, JY, Schonberger, LB, Belay, ED, Maddox, RA, Leschek, EW, Mills, JL, et al. Lower risk of Creutzfeldt-Jakob disease in pituitary growth hormone recipients initiating treatment after 1977. J Clin Endocrinol Metab. 2011; Oct 96(10):e1666–9.CrossRefGoogle ScholarPubMed

Appleby, BS, Lu, M, Bizzi, A, Phillips, MD, Berri, SM, Harbison, MD, et al. Iatrogenic Creutzfeldt-Jakob disease from commercial cadaveric human growth hormone. Emerg Infect Dis. 2013;19(4):682–4.CrossRefGoogle ScholarPubMed

Lewis, AM, Yu, M, DeArmond, SJ, Dillon, WP, Miller, BL, Geschwind, MD. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal imaging. Arch Neurol. 2006;63(2):288–90.CrossRefGoogle ScholarPubMed

Hamaguchi, T, Sakai, K, Noguchi-Shinohara, M, Nozaki, I, Takumi, I, Sanjo, N, et al. Insight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan. J Neurol Neurosurg Psychiatry. 2013;84(10):1171–5.Google Scholar